↓ Skip to main content

Dove Medical Press

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Readers on

mendeley
18 Mendeley
Title
Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
Published in
Neuropsychiatric Disease and Treatment, August 2013
DOI 10.2147/ndt.s43280
Pubmed ID
Authors

Norio Yasui-Furukori, Ayako Kaneda, Takeshi Katagai, Nrio Sugawara, Shoko Tsuchimine, Manabu Saito, Yasushi Sato, Hanako Furukori

Abstract

The Brief Assessment of Cognition in Schizophrenia (BACS) is an evaluation of cognitive function that can be completed with more cases. However, there are few studies that compare which factor, disease or aging, is a better determinant of performance on the BACS. The present study aimed to investigate the influences of disease and aging on BACS performance in schizophrenic patients using subjects with a wide range of ages.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 6%
Unknown 17 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 22%
Student > Master 4 22%
Professor > Associate Professor 3 17%
Student > Ph. D. Student 2 11%
Other 1 6%
Other 1 6%
Unknown 3 17%
Readers by discipline Count As %
Psychology 5 28%
Medicine and Dentistry 2 11%
Neuroscience 2 11%
Computer Science 1 6%
Nursing and Health Professions 1 6%
Other 2 11%
Unknown 5 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 November 2013.
All research outputs
#22,760,732
of 25,374,917 outputs
Outputs from Neuropsychiatric Disease and Treatment
#2,584
of 3,132 outputs
Outputs of similar age
#187,172
of 210,083 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#64
of 66 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,083 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.